FG, H., R, A., F, B., R, D., L, O., D, P., . . . B, G. (2023). Does real-time artificial intelligence-based visual pathology enhancement of three-dimensional optical coherence tomography scans optimise treatment decision in patients with nAMD? Rationale and design of the RAZORBILL study. The British journal of ophthalmology, 107(1), 96. https://doi.org/10.1136/bjophthalmol-2021-319211
Chicago Style (17th ed.) CitationFG, Holz, et al. "Does Real-time Artificial Intelligence-based Visual Pathology Enhancement of Three-dimensional Optical Coherence Tomography Scans Optimise Treatment Decision in Patients with NAMD? Rationale and Design of the RAZORBILL Study." The British Journal of Ophthalmology 107, no. 1 (2023): 96. https://doi.org/10.1136/bjophthalmol-2021-319211.
MLA (9th ed.) CitationFG, Holz, et al. "Does Real-time Artificial Intelligence-based Visual Pathology Enhancement of Three-dimensional Optical Coherence Tomography Scans Optimise Treatment Decision in Patients with NAMD? Rationale and Design of the RAZORBILL Study." The British Journal of Ophthalmology, vol. 107, no. 1, 2023, p. 96, https://doi.org/10.1136/bjophthalmol-2021-319211.